# US 2015/0105640 A1 · Non-invasive monitoring of physiological conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105640 A1
- Document ID: US20150105640A1
- Status: Published application
- Kind: A1
- Application number: 14/577,924
- Filed: 2014-12-19
- Published: 2015-04-16
- Earliest claimed: 2010-07-14
- Assignees: Mayo Foundation for Medical Education and Research
- Applicants: Mayo Foundation for Medical Education and Research
- Inventors: Paul A. Friedman; Kevin E. Bennet; Charles J. Bruce; Virend K. Somers
- Web page: https://patentgrep.com/patent/US20150105640A1

## CPC

- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/0006: {ECG or EEG signals}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/1477: non-invasive
- A61B 5/346: Analysis of electrocardiograms
- A61B 5/35: by template matching
- A61B 5/366: Detecting abnormal QRS complex, e.g. widening
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

This document provides methods and materials related to the non-invasive measurement of analytes in blood.

## Claims

### Claim at position 1

-15. (canceled)

### Claim 16

A method for assessing the level of an analyte within a human, the method comprising:
(a) generating, using a signal averaging technique, electrocardiogram results from said human; and
(b) comparing said results to a signal template to obtain an indication of the level of said analyte in said human,
wherein said analyte is potassium, magnesium, calcium, or glucose.

### Claim 17 (depends on 16)

The method of claim 16, further comprising generating, using the signal averaging technique, said signal template.

### Claim 18 (depends on 16)

The method of claim 16, wherein said signal template represents a level of analyte that is within the normal human physiologic range of levels for said analyte.

### Claim 19 (depends on 16)

The method of claim 16, wherein said signal template represents a level of analyte that is outside the normal human physiologic range of levels for said analyte.

### Claim 20 (depends on 16)

The method of claim 16, wherein said electrocardiogram results, when compared to said signal template, indicate that the level of said analyte in said human is within said normal human physiologic range of levels for said analyte.

### Claim 21 (depends on 16)

The method of claim 16, wherein said electrocardiogram results, when compared to said signal template, indicate that the level of said analyte in said human is outside said normal human physiologic range of levels for said analyte.

### Claim 22 (depends on 16)

The method of claim 16, wherein said analyte is potassium.

### Claim 23 (depends on 16)

The method of claim 16, wherein said analyte is magnesium.

### Claim 24 (depends on 16)

The method of claim 16, wherein said analyte is calcium.

### Claim 25 (depends on 16)

The method of claim 16, wherein said analyte is glucose.

### Claim 26

A method for assessing a change in the level of an analyte within a human as compared to a previously determined level of said analyte, wherein said method comprises:
(a) generating, using a signal averaging technique, electrocardiogram results from said human,
(b) comparing said results to a signal template to obtain an indication of the level of said analyte in said human, and
(c) comparing the level of said analyte in said human to said previously determined level of said analyte to determine a change,
wherein said change is a change that is not detectable based on visual inspection of an ECG tracing, and
wherein said analyte is potassium, magnesium, calcium, or glucose.

### Claim 27 (depends on 26)

The method of claim 26, wherein said change is less than 25 percent of the normal physiologic range of said analyte.

### Claim 28 (depends on 26)

The method of claim 26, wherein said change is less than 20 percent of the normal physiologic range of said analyte.

### Claim 29 (depends on 26)

The method of claim 26, wherein said change is less than 15 percent of the normal physiologic range of said analyte.

### Claim 30 (depends on 26)

The method of claim 26, wherein said change is less than 10 percent of the normal physiologic range of said analyte.

### Claim 31 (depends on 26)

The method of claim 26, wherein said change is less than 5 percent of the normal physiologic range of said analyte.

### Claim 32 (depends on 26)

The method of claim 26, wherein said analyte is potassium.

### Claim 33 (depends on 26)

The method of claim 26, wherein said analyte is magnesium.

### Claim 34 (depends on 26)

The method of claim 26, wherein said analyte is calcium.

### Claim 35 (depends on 26)

The method of claim 26, wherein said analyte is glucose.

### Claim 36

A method for assessing a change in the level of an analyte within a human as compared to a previously determined level of said analyte, wherein said method comprises:
(a) generating, using a signal averaging technique, an electrical recording result from an organ within said human,
(b) comparing said result to a signal template to obtain an indication of the level of said analyte in said human, and
(c) comparing the level of said analyte in said human to said previously determined level of said analyte to determine a change,
wherein said change is a change that is not detectable based on visual inspection of an electrical recording of said organ, and
wherein said analyte is potassium, magnesium, calcium, or glucose.

### Claim 37 (depends on 36)

The method of claim 36, wherein said organ is a heart.

### Claim 38 (depends on 36)

The method of claim 36, wherein said electrical recording result is an ECG tracing.

### Claim 39 (depends on 36)

The method of claim 36, wherein said analyte is potassium.

### Claim 40 (depends on 36)

The method of claim 36, wherein said analyte is magnesium.

### Claim 41 (depends on 36)

The method of claim 36, wherein said analyte is calcium.

### Claim 42 (depends on 36)

The method of claim 36, wherein said analyte is glucose.
